Time to change the paradigm for primary endpoints in cancer screening trials?
JNCI : Journal of the National Cancer Institute, 2024-05
[Peer Reviewed Journal]
EISSN: 1460-2105 ;DOI: 10.1093/jnci/djae088 ;PMID: 38777806
Digital Resources/Online E-Resources